SCHEMBL31434974

SCHEMBL31434974

COc1ncc(C)c(O)c1C(=O)N1CCNCC1

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ REN P00797 12/20 0.40
▸ PKM P14618 1/20 0.38
▸ MKNK1 Q9BUB5 1/20 0.37
▸ MKNK2 Q9HBH9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31637434 0.85 SCN9A (0.40) REN
SCHEMBL31637458 0.84 PKM (0.38) RENPKMMKNK1MKNK2
SCHEMBL31493475 0.83 LRRK2 (0.39) RENPKM
SCHEMBL31596392 0.77 CFTR (0.44) RENPKM
SCHEMBL31637789 0.74 HCRTR2 (0.31) —
SCHEMBL31289966 0.74 POLB (0.39) PKM
SCHEMBL31289703 0.72 CYP3A4 (0.44) PKM
SCHEMBL2929331 0.69 SIGMAR1 (0.46) REN
SCHEMBL16731359 0.66 SIGMAR1 (0.54) REN
SCHEMBL19145262 0.66 SIGMAR1 (0.46) MKNK1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12528806-B2 WRN inhibitors NIMBUS WADJET, INC. (US) 2026-01-20 — — US disclosed
US-12421233-B2 WRN inhibitors NIMBUS WADJET, INC. (US) 2025-09-23 — — US disclosed
US-12344609-B2 WRN inhibitors NIMBUS WADJET, INC. (US) 2025-07-01 — — US disclosed
US-20250206738-A1 WRN INHIBITORS NIMBUS DISCOVERY, INC. 2025-06-26 — — US disclosed
US-20250171442-A1 WRN INHIBITORS NIMBUS WADJET, INC. 2025-05-29 — — US disclosed
US-20250171441-A1 WRN INHIBITORS NIMBUS WADJET, INC. 2025-05-29 — — US disclosed
US-20250129069-A1 TRIAZOLO WRN INHIBITORS NIMBUS WADJET, INC. 2025-04-24 — — US disclosed
US-20250034136-A1 WRN INHIBITORS NIMBUS WADJET, INC. 2025-01-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250206738-A1 WRN INHIBITORS WRN, BLM, RECQL REN 3104/4885PKM 3180/4885MKNK1 1262/4885
US-20250171441-A1 WRN INHIBITORS WRN, BLM, RECQL REN 3104/4885PKM 3180/4885MKNK1 1262/4885
US-12421233-B2 WRN inhibitors WRN, BLM, RECQL REN 3104/4885PKM 3180/4885MKNK1 1262/4885
US-12344609-B2 WRN inhibitors WRN, BLM, RECQL REN 2910/4885PKM 3266/4885MKNK1 1426/4885
US-20250034136-A1 WRN INHIBITORS WRN, BLM, RECQL REN 3104/4885PKM 3180/4885MKNK1 1262/4885
US-20250129069-A1 TRIAZOLO WRN INHIBITORS WRN, BLM, RECQL REN 3009/4885PKM 3083/4885MKNK1 750/4885
US-20250171442-A1 WRN INHIBITORS WRN, BLM, RECQL REN 2984/4885PKM 3254/4885MKNK1 1323/4885
US-12528806-B2 WRN inhibitors WRN, RECQL, BLM REN 1035/4885PKM 3500/4885MKNK1 1222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback